136 related articles for article (PubMed ID: 1363816)
1. C1 inhibitor hinge region mutations produce dysfunction by different mechanisms.
Davis AE; Aulak K; Parad RB; Stecklein HP; Eldering E; Hack CE; Kramer J; Strunk RC; Bissler J; Rosen FS
Nat Genet; 1992 Aug; 1(5):354-8. PubMed ID: 1363816
[TBL] [Abstract][Full Text] [Related]
2. The balance between inhibition and substrate-type reactions of recombinant C1 inhibitor P5/P3 variants.
Eldering E; Huijbregts CC; Nuijens JH; Hack CE
Behring Inst Mitt; 1993 Dec; (93):125-30. PubMed ID: 8172559
[No Abstract] [Full Text] [Related]
3. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema.
Davis AE; Bissler JJ; Cicardi M
Behring Inst Mitt; 1993 Dec; (93):313-20. PubMed ID: 8172583
[TBL] [Abstract][Full Text] [Related]
5. Hereditary and acquired deficiencies of C1 inhibitor.
Davis AE
Immunodefic Rev; 1989; 1(3):207-26. PubMed ID: 2698641
[TBL] [Abstract][Full Text] [Related]
6. C1 inhibitor mutations which affect intracellular transport and secretion in type I hereditary angioedema.
Verpy E; Couture-Tosi E; Tosi M
Behring Inst Mitt; 1993 Dec; (93):120-4. PubMed ID: 8172558
[TBL] [Abstract][Full Text] [Related]
7. Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function.
Verpy E; Couture-Tosi E; Eldering E; Lopez-Trascasa M; Späth P; Meo T; Tosi M
J Clin Invest; 1995 Jan; 95(1):350-9. PubMed ID: 7814636
[TBL] [Abstract][Full Text] [Related]
8. Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.
Zahedi R; Bissler JJ; Davis AE; Andreadis C; Wisnieski JJ
J Clin Invest; 1995 Mar; 95(3):1299-305. PubMed ID: 7883978
[TBL] [Abstract][Full Text] [Related]
9. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status.
Skriver K; Wikoff WR; Patston PA; Tausk F; Schapira M; Kaplan AP; Bock SC
J Biol Chem; 1991 May; 266(14):9216-21. PubMed ID: 2026621
[TBL] [Abstract][Full Text] [Related]
10. C1 inhibitor: analysis of the role of amino acid residues within the reactive center loop in target protease recognition.
Zahedi R; MacFarlane RC; Wisnieski JJ; Davis AE
J Immunol; 2001 Aug; 167(3):1500-6. PubMed ID: 11466370
[TBL] [Abstract][Full Text] [Related]
11. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases.
Zahedi R; Wisnieski J; Davis AE
J Immunol; 1997 Jul; 159(2):983-8. PubMed ID: 9218620
[TBL] [Abstract][Full Text] [Related]
12. The structure and function of the first component of complement: genetic engineering approach (a review).
Gál P; Cseh S; Schumaker VN; Závodszky P
Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of C1 inhibitor.
Davis AE
Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
[TBL] [Abstract][Full Text] [Related]
14. A hinge region mutation in C1-inhibitor (Ala436-->Thr) results in nonsubstrate-like behavior and in polymerization of the molecule.
Aulak KS; Eldering E; Hack CE; Lubbers YP; Harrison RA; Mast A; Cicardi M; Davis AE
J Biol Chem; 1993 Aug; 268(24):18088-94. PubMed ID: 8349686
[TBL] [Abstract][Full Text] [Related]
15. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
[TBL] [Abstract][Full Text] [Related]
16. Expression of active human C1 inhibitor serpin domain in Escherichia coli.
Lamark T; Ingebrigtsen M; Bjørnstad C; Melkko T; Mollnes TE; Nielsen EW
Protein Expr Purif; 2001 Jul; 22(2):349-58. PubMed ID: 11437612
[TBL] [Abstract][Full Text] [Related]
17. Molecular defects in hereditary angioneurotic edema.
Bissler JJ; Aulak KS; Donaldson VH; Rosen FS; Cicardi M; Harrison RA; Davis AE
Proc Assoc Am Physicians; 1997 Mar; 109(2):164-73. PubMed ID: 9069585
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the serpin domain of C1 inhibitor.
Coutinho M; Aulak KS; Davis AE
J Immunol; 1994 Oct; 153(8):3648-54. PubMed ID: 7930585
[TBL] [Abstract][Full Text] [Related]
19. The C1 inhibitor deficiency. A review.
Carreer FM
Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):793-807. PubMed ID: 1489854
[TBL] [Abstract][Full Text] [Related]
20. Impaired production of both normal and mutant C1 inhibitor proteins in type I hereditary angioedema with a duplication in exon 8.
Ernst SC; Circolo A; Davis AE; Gheesling-Mullis K; Fliesler M; Strunk RC
J Immunol; 1996 Jul; 157(1):405-10. PubMed ID: 8683145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
